News

Clinical & Regulatory,Digital & Data,Drug Discovery & Development
PhaseV survey finds 88% of sponsors face five-week delays in clinical trial reporting
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
NICE recommends glycopyrronium cream for severe underarm sweating
read more
Advanced Therapies,Central Nervous System,Genomics and sequencing,Research & Development
Researchers develop electromagnetic gene switch for remote control of gene expression
read more
Drug Discovery & Development,Genomics and sequencing,Research & Development
Tagomics launches cfDNA platform for multi-organ drug safety monitoring
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
NICE recommends allergy immunotherapy tablets for children with hay fever and house dust mite allergy
read more
Biotech & Pharma Business
Prescient integrates Uptake and Dolon to create 550-strong pharma consultancy
read more
Digital & Data,Pharmaceuticals and therapeutics,Therapeutic Areas
Tris Pharma partners with Calm Health and ADHD Central to support patients
read more
Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development
US FDA inspects Aurisco site for generic oligonucleotide manufacturing
read more
Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
Remepy raises $36M to advance Parkinson’s drug into Phase 3
read more
Manufacturing & Supply Chain
University Hospital Cologne selects Celonic for anti-Pseudomonas antibody manufacturing
read more
Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Research & Development
Tufts analysis finds AI clinical monitoring could cut trial costs and development time
read more
Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Research & Development
CN Bio wins Innovate UK grant to develop human-relevant drug testing workflow
read more
Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease
read more
Advanced Therapies,Clinical & Regulatory,Genomics and sequencing,Research & Development,Therapeutic Areas
Skylark Bio doses first patient in Phase 1/2 trial for GJB2-related deafness
read more
Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
CellProthera and Alfresa sign MOU for ProtheraCytes Phase 3 trial in Japan
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
FDA approves Moderna’s mRNA flu vaccine mFLUSIVA
read more

PhaseV survey finds 88% of sponsors face five-week delays in clinical trial reporting

NICE recommends glycopyrronium cream for severe underarm sweating

Researchers develop electromagnetic gene switch for remote control of gene expression

Tagomics launches cfDNA platform for multi-organ drug safety monitoring

NICE recommends allergy immunotherapy tablets for children with hay fever and house dust mite allergy

Prescient integrates Uptake and Dolon to create 550-strong pharma consultancy

Tris Pharma partners with Calm Health and ADHD Central to support patients

US FDA inspects Aurisco site for generic oligonucleotide manufacturing

Remepy raises $36M to advance Parkinson’s drug into Phase 3

University Hospital Cologne selects Celonic for anti-Pseudomonas antibody manufacturing

Tufts analysis finds AI clinical monitoring could cut trial costs and development time

CN Bio wins Innovate UK grant to develop human-relevant drug testing workflow

FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease

Skylark Bio doses first patient in Phase 1/2 trial for GJB2-related deafness

CellProthera and Alfresa sign MOU for ProtheraCytes Phase 3 trial in Japan

FDA approves Moderna’s mRNA flu vaccine mFLUSIVA

main menu

recent posts

CN Bio wins Innovate UK grant to develop human-relevant drug testing workflow

FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease

Skylark Bio doses first patient in Phase 1/2 trial for GJB2-related deafness

get connected